ACCEL Lite: Drug-Drug Interactions of Concern in Contemporary CV Care

Medication interactions can pose a significant health risk. Identifying and understanding the degree of interaction and appropriate management allows for optimization of care while minimizing risk. In this interview, Glenn A. Hirsch, Barbara Wiggins, and Henry D. Huang discuss drug-drug interactions of concern in contemporary cardiovascular care.

Like what you hear? ACCEL Subscribers enjoy 20+ insider interviews like these every month, with CME/MOC credit and other exclusive benefits. Subscribe today for more, and check out what's new at www.acc.org/ACCEL.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Cardio-Oncology, Diabetes and Cardiometabolic Disease, Dyslipidemia, Heart Failure and Cardiomyopathies, Prevention, Pulmonary Hypertension and Venous Thromboembolism, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Pulmonary Hypertension

Keywords: ACCELLite, Drug Interactions, Pharmacology, Anticoagulants, Arrhythmias, Cardiac, Metabolic Syndrome X, Cardio-oncology, Cardiotoxicity, Dyslipidemias, Primary Prevention, Hypertension, Pulmonary


< Back to Listings